ADPV vs ZJAN
Adaptiv Select ETF vs Innovator Equity Defined Protection ETF - 1 Yr January
Which is better, ADPV or ZJAN?
Each has led over a different period.
ZJAN has a lower expense ratio. ADPV led over the full window, ZJAN over 1Y.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | ADPV | ZJAN |
|---|---|---|
| Expense Ratio | 1.00% | 0.79%Best |
| AUM | $176M | $109M |
| Dividend Yield | 0.69% | 0.00% |
| Holdings | 28 | 15 |
| YTD Return | -0.81% | +3.98%Best |
| 1Y Return | -3.77% | +5.91%Best |
| 3Y Return (annualized) | +22.15% | - |
| Volatility (annualized) | 16.3% | 2.4%Best |
| Max Drawdown | -22.3% | -3.2%Best |
| $10,000 over 1.8 years | $12,123Best | $11,130 |
| Fund Family | Adaptive ETFs | Innovator ETFs Trust |
| Category | Equity | Equity |
| Style | Large Cap Blend | Large Cap Blend |
| Inception | Nov 4, 2022 | Jan 2, 2025 |
Not shown on this pair: 5Y Return (annualized), Top 10 Weight.
Volatility and max drawdown, and the $10,000 over 1.8 years row, are measured over the window both funds cover: Jan 2, 2025 to Oct 14, 2026 (1.8 years).
ADPV vs ZJAN growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 1.8 years both funds cover.
ADPV vs ZJAN Performance
Adaptiv Select ETF (ADPV) is an ETF from Adaptive ETFs and Innovator Equity Defined Protection ETF - 1 Yr January (ZJAN) is an ETF from Innovator ETFs Trust. Over the past year ADPV returned -3.77% while ZJAN returned +5.91%. Year to date, ADPV is down 0.81% versus a gain of 3.98% for ZJAN.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
ADPV has been the more volatile fund, with annualized monthly volatility of 16.3% compared with 2.4% for ZJAN. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -22.3% for ADPV and -3.2% for ZJAN. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.64. They move together some of the time, and apart the rest.
Fees and Cost Over Time
ADPV charges 1.00% per year while ZJAN charges 0.79%. On a $10,000 position that is $100 vs $79 annually, a gap of $21 per year that compounds over a long holding period. On income, ADPV currently yields 0.69% against 0.00% for ZJAN.
You are not choosing between two funds in isolation.
Whichever of ADPV and ZJAN you pick has to sit alongside everything else you own. Add the rest and see what the combination actually holds.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, ADPV or ZJAN?
ADPV has an expense ratio of 1.00% while ZJAN charges 0.79%. ZJAN is the cheaper option, by $21 a year on a $10,000 investment.
Which performed better, ADPV or ZJAN?
Over the past year ADPV returned -3.77% vs +5.91% for ZJAN, so ZJAN leads on 1-year performance. Over the longest common window we track (2 years), ADPV annualized +11.29% vs +6.13% for ZJAN. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, ADPV or ZJAN?
ADPV has been the more volatile fund at 16.3% annualized versus 2.4% for ZJAN. Worst drawdown: ADPV -22.3% vs ZJAN -3.2%.
Should I hold both ADPV and ZJAN?
ADPV and ZJAN have a monthly-return correlation of 0.64, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
Which pays a higher dividend, ADPV or ZJAN?
ADPV yields 0.69% while ZJAN yields 0.00%, so ADPV currently pays the higher dividend yield.
Is ZJAN better than ADPV?
ZJAN has a lower expense ratio. ADPV led over the full window, ZJAN over 1Y. Which one suits a particular account depends on what it is for. This is information, not a recommendation.